TP53 and neoplasm: The underlying mechanism may be that KP patients contained the largest proportion of CD8 and activated CD4 memory T cells, supporting by previous report that TP53 and KRAS mutations had remarkable effects on increasing PD‐L1 expression, facilitating T‐cell infiltration, and augmenting tumor immunogenicity [35].